Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

2
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
2

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are free flaps a reliable solution to treat massive soft tissue defects in patients with knee periprosthetic joint infection? A systematic review and meta-analysis.

EFORT open reviews·2026
Same author

Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.

Brain : a journal of neurology·2026
Same author

A comparative study of deep learning for cortical lesion MRI segmentation with explainability analysis in multiple sclerosis.

NeuroImage. Clinical·2026
Same author

Machine learning-based combination of the central vein sign, cortical lesions and paramagnetic rim lesions: a web-based tool for the diagnosis of multiple sclerosis.

Brain communications·2026
Same author

EBV Dysregulation Is Associated With Immune Imbalance in Multiple Sclerosis: Evidence From Integrated Viral and Host Analyses.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Nonunion and complication rate after percutaneous versus open first metatarsophalangeal joint arthrodesis: a proportional meta-analysis.

Orthopaedics & traumatology, surgery & research : OTSR·2026

Related Experiment Video

Updated: Apr 18, 2026

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

11.4K

Nanomaterial applications in multiple sclerosis inflamed brain.

Clara Ballerini1, Giovanni Baldi, Alessandra Aldinucci

  • 1Department of Neurofarba, University of Florence, Viale Pieraccini, 6, 50137, Florence, Italy, clara.ballerini@unifi.it.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|January 25, 2015
PubMed
Summary

Nanomedicine utilizes nanomaterials for treating central nervous system (CNS) diseases. This review explores nanomaterials crossing the blood-brain barrier (BBB) for improved diagnosis and drug delivery in neuroinflammatory conditions like multiple sclerosis (MS).

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K
Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
08:05

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

9.8K

Related Experiment Videos

Last Updated: Apr 18, 2026

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

11.4K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K
Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
08:05

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

9.8K

Area of Science:

  • Nanomedicine and Neuroimmunology
  • Translational science in CNS disease treatment

Background:

  • Nanomaterials offer unique properties for medical applications, particularly in central nervous system (CNS) diseases.
  • Nanomedicine leverages these properties for innovative treatments and diagnostics in neurology.

Purpose of the Study:

  • To review recent developments in nanomaterials targeting the neuro-immune interface.
  • To evaluate nanomaterials for CNS inflammatory response and their application in neuroinflammatory diseases, focusing on multiple sclerosis (MS).
  • To highlight nanomaterials capable of crossing the blood-brain barrier (BBB) for targeted therapy and imaging.

Main Methods:

  • Review of recent scientific literature on nanomaterials in nanomedicine.
  • Focus on studies detailing nanomaterial interactions with the CNS and neuro-immune system.
  • Analysis of nanomaterials designed to cross the blood-brain barrier (BBB) for therapeutic and diagnostic purposes.

Main Results:

  • Nanomaterials show promise for treating inflammatory, degenerative, and tumorous CNS diseases.
  • Specific nanomaterials are being developed to overcome the blood-brain barrier (BBB) challenge.
  • Advancements in nanomedicine offer new avenues for drug delivery and imaging in neuroinflammatory conditions like MS.

Conclusions:

  • Nanomaterials are crucial for advancing nanomedicine in CNS disease management.
  • Crossing the blood-brain barrier (BBB) is a key strategy for effective CNS diagnosis and drug delivery.
  • Continued research into nanomaterials is essential for overcoming challenges in treating neuroinflammatory diseases.